Asthma
What is Asthma?
Asthma is a disease in which the airways become irritated, blocked, or narrowed. Symptoms of asthma include shortness of breath, trouble breathing, and/or tightness of the chest. Patients with asthma explain the feeling of an asthma attack as trying to breath through water while someone is squeezing your chest. Some asthma episodes can be severe and need emergency treatment to restore normal breathing.
An estimated 20 million people in the United States have asthma and, despite the availability of treatments, it remains poorly controlled among many. This health problem is the reason for nearly 500,000 hospital stays each year. Its treatment costs billions of dollars each year. Despite the far-reaching effects of asthma, much remains to be learned about what causes it and how to prevent it. Although asthma can cause severe health problems, in most cases treatment can control it and allow a person to live a normal and active life. |
Current Asthma StudiesBelow is a summary of our current trials. If you are interested in learning more, click on the trial's name to answer a few qualifying questions and request a contact by our research staff:
AZ027 Asthma study This study is 6 month study for patients 12 and older who are on current inhaled steroid therapy and have needed to take prednisone/medrol for an asthma flare in the last 12 months. No Placebo. All patients will receive either Symbicort or Pulmicort, in addition to rescue medication. Compensation for time and travel available. Fps-AS-202 "Trumpet" Study This is a 12 week Dose-ranging study to evaluate the efficacy and safety of Fp Spiromax (Fluticasone Propionate) 2 times a day with Placebo. Albuterol rescue inhaler will be provided to participants free of charge. For people 12 years of age and older with persistent asthma currently treated with an inhaled steroid. Compensation for time and travel available. Allergic Asthma A study for asthmatics ages 18 to 70 years of age who have asthma and allergies. The study medication is being tested to see its effect on asthma by reducing inflammation in the lungs and/or interfering with immune cells that trigger allergies and airway narrowing. The study medication is contained in a dry powder inhaler. The study will last approximately 3-4 months. Compensation for time and travel available. NEW! ABS-AS-304 Asthma Study A 12-week study looking at the efficacy and safety of albuterol in a dry-powder-inhaler (DPI) device for people age 12 and older with persistent asthma currently taking low-dose inhaled steroids. Albuterol is currently widely used as the go-to rescue treatment of choice for asthma attacks. Free study medication and rescue medication will be provided to study volunteers as well as no-cost study-related medical treatment. Compensation for time and travel available. |
